[1]
A. Schläpfer, C. Auclair, B. Janji, M. Karam, and M. Zaeem Noman, “The ’Holy Grail’ in Immuno-Oncology: AC BioScience SA is Aiming to Potentiate Anti-PD-1 Therapy Efficacy through Tumor Cell Conditioning Strategy”, Chimia, vol. 74, no. 10, p. 771, Oct. 2020, doi: 10.2533/chimia.2020.771.